Patent · US Active

Pyridone compound as c-met inhibitor

US10501443B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. · CN

Inventors

Xiongbin XU · Shanghai, CN
Gang Li · Beijing, CN
Charles Z. Ding · San Mateo, US
Lihong Hu · Shanghai, CN
Guoping HU · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN
Zhigang Chi · Shanghai, CN
Kun Wang · Beijing, CN

Key dates

Filing date	Oct 27, 2017
Grant date	Dec 10, 2019
Priority date	—
Expiry date	Oct 27, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed in the present invention is a type of pyridone compounds as c-met inhibitors, and specifically disclosed is a compound as shown in formula (I) or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.